Common single nucleotide polymorphisms in immunoregulatory genes and multiple myeloma risk among women in Connecticut

American Journal of Hematology

Volumn 85, Issue 8, 2010, Pages 560-563

  Lee, Kyoung Mu ^a   Baris, Dalsu ^a   Zhang, Yawei ^b   Hosgood III, H Dean ^a   Menashe, Idan ^a   Yeager, Meredith ^a   Zahm, Shelia Hoar ^a   Wang, Sophia S ^c   Purdue, Mark P ^a   Chanock, Stephen ^a   Zheng, Tongzhang ^b   Rothman, Nathaniel ^a   Lan, Qing ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE; UNITED STATES; CHROMOSOME 12; GENE; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK;

CD223 ANTIGEN; CD4 ANTIGEN; LEUKOCYTE ANTIGEN;

AGED; ANTIGENS, CD; ANTIGENS, CD4; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 12; CONNECTICUT; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENES, MHC CLASS II; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; MULTIPLE MYELOMA; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 77955480331     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21760     Document Type: Article

References (28)

1. Brown LM, Linet MS, Greenberg RS, et al. Multiple myeloma and family history of cancer among blacks and whites in the U.S. Cancer 1999;85:2385-2390.
2. Hemminki K, Li X, Czene K. Familial risk of cancer: Data for clinical counseling and cancer genetics. Int J Cancer 2004;108:109-114.
3. Mellstedt H, Holm G, Pettersson D, et al. T cells in monoclonal gammopathies. Scand J Haematol 1982;29:57-64.
4. Carter A, Silvian I, Tatarsky I, Spira G. Impaired immunoglobulin synthesis in multiple myeloma: A B-cell dysfunction. Am J Hematol 1986;22:143-154.
5. Tienhaara A, Pelliniemi TT. Peripheral blood lymphocyte subsets in multiple myeloma and monoclonal gammopathy of undetermined significance. Clin Lab Haematol 1994;16:213-223.
6. Brown EE, Lan Q, Zheng T, et al. Common variants in genes that mediate immunity and risk of multiple myeloma. Int J Cancer 2007;120:2715-2722.
7. Morgan GJ, Adamson PJ, Mensah FK, et al. Haplotypes in the tumour necrosis factor region and myeloma. Br J Haematol 2005;129:358-365.
8. Cozen W, Gebregziabher M, Conti DV, et al. Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma. Cancer Epidemiol Biomarkers Prev 2006;15:2285-2291.
9. Abazis-Stamboulieh D, Oikonomou P, Papadoulis N, et al. Association of interleukin-1A, interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms with multiple myeloma. Leuk Lymphoma 2007;48:2196-2203.
10. Kadar K, Kovacs M, Karadi I, et al. Polymorphisms of TNF-alpha and LTalpha genes in multiple myeloma. Leuk Res 2008;32:1499-1504.
11. Zheng T, Holford TR, Leaderer B, et al. Diet and nutrient intakes and risk of non- Hodgkin's lymphoma in Connecticut women. Am J Epidemiol 2004;159:454-466.
12. Chen BE, Sakoda LC, Hsing AW, Rosenberg PS. Resampling-based multiple hypothesis testing procedures for genetic case-control association studies. Genet Epidemiol 2006;30:495-507.
13. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B 1995;57:289-300.
14. Holden M, Deng S, Wojnowski L, Kulle B. GSEA-SNP: Applying gene set enrichment analysis to SNP data from genome-wide association studies. Bioinformatics 2008;24:2784-2785.
15. Joshua DE, Brown RD, Ho PJ, Gibson J. Regulatory T cells and multiple myeloma. Clin Lymphoma Myeloma 2008;8:283-286.
16. Corthay A, Skovseth DK, Lundin KU, et al. Primary antitumor immune response mediated by CD41 T cells. Immunity 2005;22:371-383.
17. Ogawara H, Handa H, Yamazaki T, et al. High Th1/Th2 ratio in patients with multiple myeloma. Leuk Res 2005;29:135-140.
18. Prabhala RH, Neri P, Bae JE, et al. Dysfunctional T regulatory cells in multiple myeloma. Blood 2006;107:301-304.
19. Ellmeier W, Sawada S, Littman DR. The regulation of CD4 and CD8 coreceptor gene expression during T cell development. Annu Rev Immunol 1999;17:523-554.
20. Siu G. Controlling CD4 gene expression during T cell lineage commitment. Semin Immunol 2002;14:441-451.
21. Kristiansen OP, Karlsen AE, Larsen ZM, et al. Danish IDDM epidemiology and genetics group and Danish study group of IDDM in childhood. Identification of a type 1 diabetes-associated CD4 promoter haplotype with high constitutive activity. Scand J Immunol 2004;59:582-591.
22. Lo SF, Wan L, Lin HC, et al. Association of CD4 enhancer gene polymorphisms with rheumatoid arthritis and systemic lupus erythematosus in Taiwan. J Rheumatol 2008;35:2113-2118.
23. Zamani M, Tabatabaiefar MA, Mosayyebi S, et al. Possible association of the CD4 gene polymorphism with vitiligo in an Iranian population. Clin Exp Dermatol 2009 Oct 19. [Epub ahead of print].
24. Lundmark F, Harbo HF, Celius EG, et al. Association analysis of the LAG3 and CD4 genes in multiple sclerosis in two independent populations. J Neuroimmunol 2006;180:193-198.
25. Ghabanbasani MZ, Buyse I, Legius E, et al. Possible association of CD3 and CD4 polymorphisms with insulin-dependent diabetes mellitus (IDDM). Clin Exp Immunol 1994;97:517-521.
26. Oyugi JO, Vouriot FC, Alimonti J, et al. A common CD4 gene variant is associated with an increased risk of HIV-1 infection in Kenyan female commercial sex workers. J Infect Dis 2009;199:1327-1334.
27. Choi RY, Farquhar C, Juno J, et al. Infant CD4 C868T polymorphism is associated with increased human immunodeficiency virus (HIV-1) acquisition. Clin Exp Immunol 2010 Feb 2. [Epub ahead of print].
28. Kisielow M, Kisielow J, Capoferri-Sollami G, Karjalainen K. Expression of lymphocyte activation gene 3 (LAG-3) on B cells is induced by T cells. Eur J Immunol 2005;35:2081-2088.